US › Healthcare

Cytek Biosciences Inc (CTKB)

US · Healthcare · Medical Devices

$4.28-0.70%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$44.1M
Revenue YoY
+6.5%
Net profit
$-18.9M
Profit YoY
-65.5%
EPS
$-0.10
EPS estimate
$-0.08
Net margin
-42.7%

EPS came in at -0.10 against a street estimate of -0.08 — a miss of 25.0%.

Key statistics

Market cap
$556.6M
Forward P/E
370.4
P/B
1.66
Book value
$2.54
EPS (TTM)
$-0.58
52-week high
$6.18
52-week low
$3.28
50-day MA
$4.29
200-day MA
$4.57
Beta
1.17

Analyst view

Analysts rate Cytek Biosciences Inc a hold (2 buy, 3 hold, 1 sell out of 6) with an average price target of $5.69.

Shareholding

Insiders
8.42%
Institutions
66.23%

Largest institutional holders

FundStake
BlackRock Inc13.17%
Vanguard Group Inc5.79%
Topline Capital Management LLC5.47%
Hillhouse Capital Advisors, Ltd.5.15%
Millennium Management LLC4.87%
Boston Partners Global Investors, Inc4.49%
Vanguard Capital Management, LLC3.69%
State Street Corp3.19%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Cytek Biosciences Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.